Control of AC133/CD133 and impact on human hematopoietic progenitor cells through nucleolin
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/leu2015146.pdf
Reference60 articles.
1. Yin AH, Miraglia S, Zanjani ES, Almeida-Porada G, Ogawa M, Leary AG et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997; 90: 5002–5012.
2. Bauer N, Fonseca AV, Florek M, Freund D, Jászai J, Bornhäuser M et al. New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133). Cells Tissues Organs 2008; 188: 127–138.
3. Corbeil D (ed) Prominin-1 (CD133): New Insights on Stem & Cancer Stem Cell Biology 1st edn. Springer: New York, NY, USA, 2013.
4. Gallacher L, Murdoch B, Wu DM, Karanu FN, Keeney M, Bhatia M . Isolation and characterization of human CD34-Lin- and CD34+Lin- hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 2000; 95: 2813–2820.
5. Takahashi M, Matsuoka M, Sumide K, Nakatsuka R, Fujioka T, Kohno H . CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells. Leukemia 2014; 28: 1308–1315.
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of non-charged 7.44 analogs interacting with the NHR2 domain of RUNX1-ETO and exhibiting an improved, selective antiproliferative effect in RUNX-ETO positive cells;2024-06-12
2. A Concise Review of Prodigious Salinomycin and Its Derivatives Effective in Treatment of Breast Cancer: (2012–2022);International Journal of Translational Medicine;2023-05-05
3. Single-cell transcriptome profiling of human HSCs during development: new insights into HSC ontogeny;Signal Transduction and Targeted Therapy;2023-02-06
4. Impairment of Nucleolin Activity and Phosphorylation by a Trachylobane Diterpene from Psiadia punctulata in Cancer Cells;International Journal of Molecular Sciences;2022-09-27
5. Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 Dimerization;ACS Central Science;2022-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3